Mourre Christiane, Manrique Christine, Camon Jeremy, Aidi-Knani Sabrine, Deltheil Thierry, Turle-Lorenzo Nathalie, Guiraudie-Capraz Gaelle, Amalric Marianne
Aix Marseille Univ, CNRS, LNC, FR3C, Marseille, France.
Aix Marseille Univ, CNRS, FR3C, 13331, Marseille, France.
Neuropharmacology. 2017 Feb;113(Pt A):519-532. doi: 10.1016/j.neuropharm.2016.11.003. Epub 2016 Nov 5.
Parkinson's disease (PD) is a progressive neurodegenerative disease originating from the loss of dopamine (DA) neurons in the substantia nigra pars compacta (SNC). The small-conductance calcium-activated potassium (SK) channels play an essential role in the regulation of midbrain DA neuron activity patterns, as well as excitability of other types of neurons of the basal ganglia. We therefore questioned whether the SK channel expression in the basal ganglia is modified in parkinsonian rats and how this could impact behavioral performance in a reaction time task. We used a rat model of early PD in which the progressive nigrostriatal DA degeneration was produced by bilateral infusions of 6-hydroxydopamine (6-OHDA) into the striatum. In situ hybridization of SK2 and SK3 mRNA and binding of iodinated apamin (SK2/SK3 blocker) were performed at 1, 8 or 21 days postsurgery in sham and 6-OHDA lesion groups. A significant decrease of SK3 channel expression was found in the SNC of lesioned animals at the three time points, with no change of SK2 channel expression. Interestingly, an upregulation of SK2 mRNA and apamin binding was found in the subthalamic nucleus (STN) at 21 days postlesion. These results were confirmed using quantitative real time polymerase chain reaction (qRT-PCR) approach. Functionally, the local infusion of apamin into the STN of parkinsonian rats enhanced the akinetic deficits produced by nigrostriatal DA lesions in a reaction time task while apamin infusion into the SNC had an opposite effect. These effects disappear when the positive modulator of SK channels (CyPPA) is co-administered with apamin. These findings suggest that an upregulation of SK2 channels in the STN may underlie the physiological adjustment to increased subthalamic excitability following partial DA denervation.
帕金森病(PD)是一种进行性神经退行性疾病,源于黑质致密部(SNC)中多巴胺(DA)神经元的丧失。小电导钙激活钾(SK)通道在调节中脑DA神经元活动模式以及基底神经节其他类型神经元的兴奋性方面起着至关重要的作用。因此,我们质疑帕金森病大鼠基底神经节中SK通道的表达是否发生改变,以及这如何影响反应时间任务中的行为表现。我们使用了早期帕金森病大鼠模型,通过向纹状体双侧注射6-羟基多巴胺(6-OHDA)来诱导进行性黑质纹状体DA变性。在假手术组和6-OHDA损伤组术后1天、8天或21天,对SK2和SK3 mRNA进行原位杂交,并进行碘化蜂毒明(SK2/SK3阻断剂)结合实验。在三个时间点,损伤动物的SNC中均发现SK3通道表达显著降低,而SK2通道表达无变化。有趣的是,在损伤后21天,丘脑底核(STN)中发现SK2 mRNA和蜂毒明结合上调。这些结果通过定量实时聚合酶链反应(qRT-PCR)方法得到证实。在功能上,向帕金森病大鼠的STN局部注射蜂毒明,在反应时间任务中增强了黑质纹状体DA损伤产生的运动不能缺陷,而向SNC注射蜂毒明则产生相反的效果。当SK通道的正性调节剂(CyPPA)与蜂毒明共同给药时,这些效果消失。这些发现表明,STN中SK2通道的上调可能是部分DA去神经支配后丘脑底核兴奋性增加的生理调节基础。
Int J Neuropsychopharmacol. 2014-8
J Neurosci Res. 2023-11
Neurobiol Dis. 2023-1
Pharmaceuticals (Basel). 2021-11-26
Front Mol Neurosci. 2021-6-3
Int J Mol Sci. 2021-3-16